Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...

When it comes to losing weight, Al Roker is the last person to give anyone insight into reaching the finish line. The 70-year ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Norvo Nordisk, a global healthcare company, is currently involved in a product liability lawsuit against its Ozempic brand, a ...

Ozempic, a popular weight-loss drug, has helped many shed pounds and improve their health. However, discontinuing the ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

Online conversations about Ozempic and similar medications are full of misinformation — and echo decades of flawed teachings ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...